Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$7.13 - $9.49 $24,598 - $32,740
-3,450 Reduced 25.23%
10,225 $91,000
Q3 2023

Oct 19, 2023

SELL
$7.77 - $12.27 $5,050 - $7,975
-650 Reduced 4.54%
13,675 $106,000
Q2 2023

Jul 17, 2023

SELL
$8.96 - $11.69 $29,120 - $37,992
-3,250 Reduced 18.49%
14,325 $138,000
Q1 2023

Apr 20, 2023

BUY
$5.94 - $11.27 $4,455 - $8,452
750 Added 4.46%
17,575 $192,000
Q3 2022

Oct 31, 2022

SELL
$6.66 - $12.39 $193,473 - $359,929
-29,050 Reduced 63.32%
16,825 $127,000
Q2 2022

Jul 29, 2022

SELL
$8.95 - $12.8 $36,695 - $52,480
-4,100 Reduced 8.2%
45,875 $461,000
Q1 2022

May 11, 2022

SELL
$10.05 - $22.48 $349,488 - $781,742
-34,775 Reduced 41.03%
49,975 $619,000
Q4 2021

Jan 10, 2022

BUY
$17.78 - $33.08 $243,141 - $452,369
13,675 Added 19.24%
84,750 $1.94 Million
Q3 2021

Nov 24, 2021

BUY
$10.93 - $23.55 $76,236 - $164,261
6,975 Added 10.88%
71,075 $1.57 Million
Q2 2021

Jul 30, 2021

BUY
$10.0 - $14.52 $64,250 - $93,291
6,425 Added 11.14%
64,100 $831,000
Q1 2021

Apr 29, 2021

BUY
$12.3 - $18.73 $367,770 - $560,027
29,900 Added 107.65%
57,675 $749,000
Q4 2020

Jan 15, 2021

BUY
$12.94 - $16.05 $233,890 - $290,103
18,075 Added 186.34%
27,775 $384,000
Q3 2020

Oct 21, 2020

SELL
$13.19 - $16.66 $3,297 - $4,165
-250 Reduced 2.51%
9,700 $143,000
Q2 2020

Jul 10, 2020

SELL
$14.12 - $18.33 $26,828 - $34,827
-1,900 Reduced 16.03%
9,950 $162,000
Q1 2020

Apr 15, 2020

BUY
$11.34 - $21.46 $81,648 - $154,512
7,200 Added 154.84%
11,850 $172,000
Q4 2019

Jan 22, 2020

SELL
$3.88 - $21.42 $56,260 - $310,590
-14,500 Reduced 75.72%
4,650 $94,000
Q3 2019

Oct 25, 2019

BUY
$5.34 - $6.59 $22,962 - $28,337
4,300 Added 28.96%
19,150 $102,000
Q1 2019

Apr 29, 2019

SELL
$6.06 - $7.64 $12,120 - $15,280
-2,000 Reduced 11.87%
14,850 $97,000
Q4 2018

Feb 04, 2019

SELL
$5.08 - $6.83 $16,002 - $21,514
-3,150 Reduced 15.75%
16,850 $115,000
Q3 2018

Oct 30, 2018

BUY
$5.27 - $6.64 $41,106 - $51,792
7,800 Added 63.93%
20,000 $133,000
Q1 2018

May 14, 2018

BUY
$4.85 - $5.99 $5,335 - $6,589
1,100 Added 9.91%
12,200 $62,000
Q4 2017

Feb 14, 2018

BUY
$4.53 - $7.09 $50,283 - $78,699
11,100
11,100 $57,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.